# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Jun 25, 2026

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2026-06-25
- Accepted by EDGAR: Jun 25, 2026, 17:03 ET
- Period: 2026-06-25
- Accession: 0001193125-26-283007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm

Filed Jun 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-283007. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.
